These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25938799)

  • 41. Mechanisms of type I interferon signaling in normal and malignant cells.
    Li Y; Srivastava KK; Platanias LC
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The interferon response to bacterial and viral infections.
    Pietras EM; Saha SK; Cheng G
    J Endotoxin Res; 2006; 12(4):246-50. PubMed ID: 16953977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential expression and activity of the porcine type I interferon family.
    Sang Y; Rowland RR; Hesse RA; Blecha F
    Physiol Genomics; 2010 Jul; 42(2):248-58. PubMed ID: 20406849
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Negative feedback contributes to the stochastic expression of the interferon-β gene in virus-triggered type I interferon signaling pathways.
    Zhang W; Tian T; Zou X
    Math Biosci; 2015 Jul; 265():12-27. PubMed ID: 25892253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viruses and the type I interferon antiviral system: induction and evasion.
    Basler CF; García-Sastre A
    Int Rev Immunol; 2002; 21(4-5):305-37. PubMed ID: 12486817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Action of type III IFNs and their roles in immune responses].
    Domagalski K; Tretyn A; Pawłowska M; Szczepanek J; Halota W
    Postepy Hig Med Dosw (Online); 2010 Oct; 64():522-33. PubMed ID: 21109705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils.
    Stegelmeier AA; Darzianiazizi M; Hanada K; Sharif S; Wootton SK; Bridle BW; Karimi K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon Lambda Genetics and Biology in Regulation of Viral Control.
    Hemann EA; Gale M; Savan R
    Front Immunol; 2017; 8():1707. PubMed ID: 29270173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene.
    Schmeisser H; Mejido J; Balinsky CA; Morrow AN; Clark CR; Zhao T; Zoon KC
    J Virol; 2010 Oct; 84(20):10671-80. PubMed ID: 20686046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type I interferons link viral infection to enhanced epithelial turnover and repair.
    Sun L; Miyoshi H; Origanti S; Nice TJ; Barger AC; Manieri NA; Fogel LA; French AR; Piwnica-Worms D; Piwnica-Worms H; Virgin HW; Lenschow DJ; Stappenbeck TS
    Cell Host Microbe; 2015 Jan; 17(1):85-97. PubMed ID: 25482432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.
    Andreakos E; Salagianni M; Galani IE; Koltsida O
    Front Immunol; 2017; 8():1232. PubMed ID: 29033947
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.
    Galani V; Kastamoulas M; Varouktsi A; Lampri E; Mitselou A; Arvanitis DL
    Clin Exp Med; 2017 Aug; 17(3):281-289. PubMed ID: 27416926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNAs in the Type I Interferon Antiviral Response.
    Suarez B; Prats-Mari L; Unfried JP; Fortes P
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections.
    Ahmed CM; Johnson HM
    J Interferon Cytokine Res; 2014 Oct; 34(10):802-9. PubMed ID: 24811478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Type I interferons in viral control and immune regulation.
    Teijaro JR
    Curr Opin Virol; 2016 Feb; 16():31-40. PubMed ID: 26812607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting IFN-λ: therapeutic implications.
    Eslam M; George J
    Expert Opin Ther Targets; 2016 Dec; 20(12):1425-1432. PubMed ID: 27681264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genome-Wide Gene Expression Analysis Reveals Unique Genes Signatures of Epithelial Reorganization in Primary Airway Epithelium Induced by Type-I, -II and -III Interferons.
    Erb A; Zissler UM; Oelsner M; Chaker AM; Schmidt-Weber CB; Jakwerth CA
    Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell Polarization and Epigenetic Status Shape the Heterogeneous Response to Type III Interferons in Intestinal Epithelial Cells.
    Bhushal S; Wolfsmüller M; Selvakumar TA; Kemper L; Wirth D; Hornef MW; Hauser H; Köster M
    Front Immunol; 2017; 8():671. PubMed ID: 28659914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In Vitro and In Vivo Preclinical Effects of Type I IFNs on Gliomas.
    Galani V; Papadatos SS; Alexiou G; Galani A; Kyritsis AP
    J Interferon Cytokine Res; 2017 Apr; 37(4):139-146. PubMed ID: 28387596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IFN-α subtypes: distinct biological activities in anti-viral therapy.
    Gibbert K; Schlaak JF; Yang D; Dittmer U
    Br J Pharmacol; 2013 Mar; 168(5):1048-58. PubMed ID: 23072338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.